Search results
Results from the WOW.Com Content Network
Cepacol (/ ˈ s iː p ə k ɒ l / SEE-pə-kol styled Cēpacol) is an American brand of personal hygiene products, as well as for relief of sore throat. It is distributed in the US by Reckitt. [1] The brand was originally owned by J.B. Williams. Following acquisition by Combe Incorporated, Combe Incorporated sold Cepacol to Reckitt Benckiser in ...
Cetylpyridinium chloride is known to cause tooth staining in approximately 3 percent of users. [14] The Crest brand has noted that this staining is actually an indication that the product is working as intended, as the stains are a result of bacteria dying on the teeth. [15]
In 1966 the Federal Trade Commission ordered Merck and Company to discontinue the false claims of germ-killing and pain-relieving properties for its Sucrets and Children's Sucrets throat lozenges. [4] In 1977, it was acquired by Beecham, later merging with SmithKline Beckman in 1989 to form SmithKline Beecham.
Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996.. The company specialized in bringing to market drugs that had been discovered but unmarketed by other companies including Cardizem which treats arrhythmias and high blood pressure, Carafate (an ulcer treatment), Gaviscon (an antacid), Seldane (a ...
In October 2002, Combe acquired J.B. Williams, thereby adding such longtime names as Brylcreem, Aqua Velva and Cepacol to its brand stable. [3] In January 2011, Combe sold its cough remedy and skin care business to Reckitt Benckiser, and its foot care business (including Odor-Eaters) to Blistex. [4] [5]
The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th Model List of Essential Medicines for Children). Geneva: World Health Organization. hdl: 10665/259481. ISBN 978-92-4-121015-7. ISSN 0512-3054. WHO technical report series; no. 1006.
The BNF for Children developed from the British National Formulary (BNF), which prior to 2005 had provided information on the treatment of children, with the doses largely determined by calculations based on the body weight of the child. The guidance was provided by pharmacists and doctors whose expertise was in the care of adults.
Business portal; This article is within the scope of WikiProject Business, a collaborative effort to improve the coverage of business articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.